Physiologic and cytotoxic effects of tirapazamine in tumor-bearing mice
- 1 January 1997
- journal article
- Published by Wiley in Radiation Oncology Investigations
- Vol. 5 (5) , 213-219
- https://doi.org/10.1002/(sici)1520-6823(1997)5:5<213::aid-roi1>3.0.co;2-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. I. TirapazamineBritish Journal of Cancer, 1995
- Contribution of Transient Blood Flow to Tumour Hypoxia in MiceActa Oncologica, 1995
- Modulation of tumor hypoxia by conventional chemotherapeutic agentsInternational Journal of Radiation Oncology*Biology*Physics, 1994
- SR 4233 (Tirapazamine): a new anticancer drug exploiting hypoxia in solid tumoursBritish Journal of Cancer, 1993
- Evaluation of bioreductive drugs in multicell spheroidsInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Distribution, Oxygenation, and Clonogenicity of Macrophages in a Murine TumorCancer Communications, 1989
- SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cellsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Cell selection from a murine tumour using the fluorescent probe Hoechst 33342British Journal of Cancer, 1985
- Studies on a New Human Cell Line (SiHa) Derived from Carcinoma of Uterus. I. Its Establishment and MorphologyExperimental Biology and Medicine, 1970
- The Histological Structure of Some Human Lung Cancers and the Possible Implications for RadiotherapyBritish Journal of Cancer, 1955